Air Voel, one of Canada’s trusted providers of sleep therapy solutions, is proud to announce a major expansion of its offerings across the country, making advanced ResMed CPAP machines more accessible ...

Tariffs on medical devices would push up prices and disrupt research and development efforts at the expense of US patients, ...

ResMed has seen its fair value estimate edge up slightly from $291.86 to $295.13, as recent improvements in margin expectations have contributed to this change. This modest increase comes amid ongoing ...

Analysts on Wall Street project that ResMed (RMD) will announce quarterly earnings of $2.49 per share in its forthcoming report, representing an increase of 13.2% year over year. Revenues are ...

Hello, and welcome to the Q1 Fiscal Year 2026 ResMed Earnings Conference Call. My name is Kevin. I'll be your operator for today's call. [Operator Instructions] Also, please note, this conference call ...

ResMed (NYSE:RMD) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. Summarizing their recent assessments, the table below illustrates ...

Investors in ResMed Inc. RMD need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 16, 2026 $155.00 Call had some of the highest implied ...

With the growing emphasis on respiratory wellness and early intervention for sleep disorders, the UK CPAP market is poised to ...

Using different oximeter devices for monitoring stable patients under NIV or CPAP may have an unpredictable effect on results and clinical decisions.

Gift 5 articles to anyone you choose each month when you subscribe. It’s the oldest trick in the Aussie investor’s playbook: buy the nation’s biggest companies, and just hold ’em. A measure of just ...